Oncology1 year ago
Immunotherapy is effective for some patients, but it is expensive, and its use is still not ideal
According to research that was published by Evernorth Research Institute1, novel immunotherapies hold promise for certain patient groups, but their clinical use remains suboptimal. For instance,...
